Providing innovative solutions for over 30 years
We provide our customers with innovative bioanalytical solutions for protein and cell biology in life science research, pharmaceutical and biotherapeutic development.
With over 140,000 placements in laboratories around the world, our instruments have contributed to remarkable scientific research described in over 150,000 peer reviewed publications. Included within a broad product portfolio are platforms for high-throughput screening, genomic and cellular analysis, colony selection and microplate detection. We are over 1,100 associates strong with rich domain knowledge to support scientific breakthroughs. We are headquartered in Silicon Valley, the center of technology and innovation, with offices around the globe.
First microplate reader in space
Molecular Devices SpectraMax M5e reader, chosen for its durability, became the first microplate reader in space in May 2011. NanoRacks, a leading provider of commercial pathway solutions aboard the International Space Station, added the reader to their line of commercial research hardware, providing researchers the ability to conduct microplate reader experiments in microgravity for the first time.
They reconfigured the reader to operate comfortably in the zero-gravity environment of the space station. Upgrades included temperature control and the ability to configure every aspect of the researcher’s experiment from an Earth-based workstation using SoftMax® Pro, the leading data acquisition and analysis software. NanoRacks re-launched the reconfigured SpectraMax M5e reader back to the International Space Station on the SpaceX Commercial Resupply Mission-9 on July 18, 2016.
We have implemented and successfully maintained a Quality Management System focusing all its processes across the entire value delivery chain on customer satisfaction and continual improvement.
Our Quality Management System is compliant to the requirements of ISO9001:2008 International Standard that enhances our ability to design, develop, manufacture, deliver, maintain and support our products according to the highest quality standards continually and consistently.
Our commitment is reflected in our Quality Policy: Customer Focused, Quality Driven: We are committed to keeping our promises and to continually improve our products, services, and processes so that we consistently meet or exceed our customers’ expectations.
At Molecular Devices, LLC, our products are RoHS compliant and meet material restriction requirements adopted under European RoHS, Directive 2011/65/EU. This legislation restricts the use of Lead, Cadmium, Mercury, Hexavalent Chromium, Poly-Brominated Bi-Phenyls (PBB), and Poly-Brominated Di-Phenyl Ethers (PBDE) in products that are put on the market in EU member countries.
China RoHS Certified
Under the Waste Electrical and Electronic Equipment (WEEE) Directive and implementing regulations, when customers buy new electrical and electronic equipment from Molecular Devices they are entitled to:
- send old equipment for recycling on a one-for-one, like-for-like basis (this varies depending on the country)
- send the new equipment back for recycling when this ultimately becomes waste
Instructions to both customers and recyclers/treatment facilities wishing to obtain disassembly information are found on the WEEE Information page.
At Molecular Devices, we provide one of the widest ranges of bioanalytical systems for life science and drug discovery research available from a single supplier. Our systems are built on proprietary technology platforms that deliver high performance, flexibility, and reliability. Some of our key patented technologies can be viewed here. For more information about any of these technologies, please contact us directly.
Integrity & Compliance
Please visit www.danaher.com/how-we-work/integrity-and- compliance for a copy of our Standards of Conduct, to make a report on the Danaher Integrity and Compliance Helpline, and for details regarding Danaher and its subsidiaries’ compliance with the California Transparency in Supply Chains Act of 2010.
Modern Slavery Act 2015 Compliance
Please visit http://investors.danaher.com/corporate-governance (under Policies & Reports) for details regarding Danaher and its subsidiaries’ compliance with the Modern Slavery Act 2015.
Molecular Devices officially opens new headquarters in Silicon ValleyRead
Molecular Devices and ForteBio combine to create new Biologics Solutions business unit to drive integrated workflow offerings for drug discovery and developmentRead
Molecular Devices launches the ImageXpress Pico systemRead
Are you passionate about designing, building, and supporting industry-leading solutions that help improve the quality of human life every single day? Join us and work with best-in-class teams to build innovative tools that advance our customers’ scientific discoveries.
Join our team